There are currently 88 clinical trials in Galveston, Texas looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Texas Medical Branch, University of Texas Medical Branch at Galveston, Univ TX Galveston Med Branch and The University of Texas Medical Branch. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
CCT-102 vs. Expectant Management in Delayed Pregnancy Loss
NCT06121063
Recruiting
A Phase 3, multi-center clinical trial of a CCT-102 regimen compared to expectant management to promote uterine evacuation in first trimester non-progressing Delayed Pregnancy Loss (DPL).
Gender:
Female
Ages:
Between 18 years and 50 years
Trial Updated:
02/14/2024
Locations: The University of Texas Medical Branch at Galveston, Galveston, Texas
Conditions: Early Pregnancy Loss, Delayed Pregnancy Loss
Register for Updates
PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
NCT02282969
Recruiting
Objectives: This protocol addresses the first phase of a larger project funded by the Patient-Centered Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted for the larger, comparative study. In this initial development phase, our prototype patient decision aid will be updated to reflect current guidelines about lung cancer screening. The updated aid will then be pil... Read More
Gender:
All
Ages:
Between 55 years and 80 years
Trial Updated:
02/08/2024
Locations: The University of Texas Medical Branch at Galveston, Galveston, Texas
Conditions: Health Knowledge, Attitudes, Practice
Register for Updates
Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules
NCT04171492
Recruiting
This study evaluates the how addition of the Nodify XL2 test result impacts the clinical management of newly identified solid lung nodules assessed as low to moderate risk of cancer.
Gender:
All
Ages:
40 years and above
Trial Updated:
02/06/2024
Locations: University of Texas Medical Branch, Galveston, Texas
Conditions: Nodule Solitary Pulmonary, Non-small Cell Carcinoma
Register for Updates
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer
NCT03775265
Recruiting
This phase III trial studies how well chemotherapy and radiation therapy work with or without atezolizumab in treating patients with localized muscle invasive bladder cancer. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as gemcitabine, cisplatin, fluorouracil and mitomycin-C, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving c... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/03/2024
Locations: University of Texas Medical Branch, Galveston, Texas
Conditions: Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma
Register for Updates
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
NCT03487185
Recruiting
A randomized controlled trial of 1,500 women to assess whether treatment of obstructive sleep apnea with continuous positive airway pressure (CPAP) in pregnancy will result in a reduction in the rate of hypertensive disorders of pregnancy.
Gender:
Female
Ages:
18 years and above
Trial Updated:
02/02/2024
Locations: University of Texas Medical Branch, Galveston, Texas
Conditions: Obstructive Sleep Apnea of Adult, Preeclampsia, Obstetrical Complications
Register for Updates
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
NCT02488967
Recruiting
This randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer. Drugs used in chemotherapy, such as doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whethe... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/29/2024
Locations: University of Texas Medical Branch, Galveston, Texas
Conditions: Breast Adenocarcinoma, Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer, Triple-Negative Breast Carcinoma
Register for Updates
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
NCT03511118
Recruiting
Over half of women in the US who are breastfeeding their infants take prescription drugs. You are being asked to participate in this study because you are breastfeeding your infant and are currently taking, as part of your medical care, at least one of the drugs we are studying. We are interested in studying drugs commonly prescribed to women who are breastfeeding so we can learn more about the amount of drug that is transferred to breastmilk and estimate how much of drug that is consumed by bre... Read More
Gender:
All
Ages:
All
Trial Updated:
01/23/2024
Locations: University of Texas Medical Branch - Galveston, Galveston, Texas
Conditions: Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI
Register for Updates
The Gut Microbiome and Immunotherapy Response in Solid Cancers
NCT06050733
Recruiting
The aim of this study is characterize the gastrointestinal microbiomes of patient with solid cancer undergoing standard of care treatment with programmed cell death protein 1 (PD-1) /programmed cell death ligand (PD-L1) blockade.
Gender:
All
Ages:
Between 35 years and 75 years
Trial Updated:
01/18/2024
Locations: University of Texas Medical Branch, Galveston, Texas
Conditions: Cancer
Register for Updates
Intravitreal Injection Site and Perceived Pain
NCT05640895
Recruiting
The objective of this study is to explore the perception of pain during intravitreal injection related to the distance of the entry site from the limbus.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
01/18/2024
Locations: University of Texas Medical Branch, Galveston, Texas
Conditions: Pain
Register for Updates
Effectiveness of Healthy Habits for Hospitalized Older Adults to Optimize Rehabilitation
NCT04269239
Recruiting
This study aims to evaluate behavioral interventions in conjunction with medical rehabilitation to promote functional health in patients recovering from orthopedic surgery. Half of the subjects in this study will be assigned to an intervention that meets with a study therapist to discuss implementing healthy habits. The other half of subjects will assigned to an intervention group that meets with a study therapists to discuss implementing healthy sleep habits. Both groups will undergo several ph... Read More
Gender:
All
Ages:
40 years and above
Trial Updated:
01/10/2024
Locations: University of Texas Medical Branch, Galveston, Texas
Conditions: Insomnia, Pain, Osteoarthritis, Knee, Osteoarthritis, Hip
Register for Updates
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function
NCT04763200
Recruiting
The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart procedure compared to the current standard of care.
Gender:
All
Ages:
Between 18 years and 90 years
Trial Updated:
12/29/2023
Locations: University of Texas Medical Branch (UTMB) Galveston, Galveston, Texas
Conditions: Left Ventricular Dysfunction, Coronary Artery Disease
Register for Updates
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
NCT03298802
Recruiting
Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.
Gender:
Female
Ages:
Between 18 years and 50 years
Trial Updated:
12/01/2023
Locations: University of Texas Medical Branch, Galveston, Texas
Conditions: Pre-Eclampsia, Gestational Hypertension, Superimposed Pre-Eclampsia, Hypertension, Pregnancy-Induced, Postpartum Pregnancy-Induced Hypertension, Postpartum Preeclampsia
Register for Updates